NEW YORK, March 21, 2023 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), in connection with its proposed merger with MEI Pharma, Inc. ("MEI Pharma"). Under the terms of the merger agreement, INFI will become a wholly owned subsidiary of MEI Pharma. Pursuant to an exchange ratio set forth in the merger agreement, MEI Pharma shareholders are expected to own approximately 58.0% and INFI shareholders are expected to only own approximately 42.0% of the outstanding equity of the combined company immediately following the merger. If you own INFI shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/infi
INDUS Realty Trust, Inc. (NASDAQ: INDT)
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of INDUS Realty Trust, Inc. (NASDAQ: INDT), in connection with the proposed acquisition of INDT by affiliates of Centerbridge Partners, L.P. Under the terms of the merger agreement, INDT shareholders will receive $67.00 for each share of INDT common stock owned. If you own INDT shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/indt
Sumo Logic, Inc. (NASDAQ: SUMO)
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sumo Logic, Inc. (NASDAQ: SUMO), in connection with the proposed acquisition of SUMO by affiliates of Francisco Partners. Under the terms of the merger agreement, SUMO shareholders will receive $12.05 in cash for each share of SUMO common stock owned. If you own SUMO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/sumo
Malvern Bancorp, Inc. (NASDAQ: MLVF)
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Malvern Bancorp, Inc. (NASDAQ: MLVF), in connection with the proposed acquisition of MLVF by First Bank ("First Bank"). Under the merger agreement, MLVF shareholders will receive 0.7733 shares of First Bank common stock, plus $7.80 in cash for each outstanding MLVF share, representing implied per-share consideration of $16.31 based upon First Bank's March 20, 2023 closing price of $11.00. If you own MLVF shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/mlvf
SOURCE Weiss Law
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article